Med. Pro Praxi 2009; 6(5): 265-269
Treatment of acute attack of primary headache
- Radiodiagnostická klinika 1. LF UK, oddělení magnetické rezonance, Praha
Tension headache is the most often primary headache, which is astringent, dull and diffuse. Treatment includes analgesics, non-steroidal
antirheumatics (NSA) and anxiolytics, resp. myorelaxants. Migraine is a primary headache with repeated seizures predominantly of hemicrania
type accompanied with nausea, vomiting, photophobia or other additive symptoms. Treatment of acute attack is oral if patient is not
vomitting mostly by analgesics or NSA. Serotonine receptor agonists – triptans represent specific treatment. If patient vomits antiemetics
are recommended or parenteral treatment is necessary. Cluster headache and paroxysmal hemicrania are rare units, their treatment is
discussed in the text. Migrainous status represents a serious complication of migraine, with specific parenteral treatment.
Keywords: primary headache, acute attack of migraine, triptans.
Published: December 1, 2009 Show citation
References
- Headache Classification Subcommittee of the International Headache Society. The International Classification and diagnostic criteria of headache disorders. 2nd edition. Cephalalgia 2004; 24(Suppl. 1): 1-160.
- Opavský J, Keller O, et al. Česká verze revidované mezinárodní klasifikace bolestí hlavy (ICHD - II) navržené a předložené Mezinárodní společností pro bolesti hlavy. Čes Slov Neurol Neurochir 2005; 68/101(2): 133-138.
- Peterová V, Schickerová R. Problematika léčby bolesti hlavy. Med Rev 1995; 2(7): 15-17.
- Peterová V, Seidl Z, Obenberger J. Ketoprofen v léčbě bolesti hlavy. Prakt Lék 2000; 80(1): 35-36.
- Peterová V, Obenberger J, Seidl Z. Léčba bolestí hlavy ovlivněním úzkosti. Prakt lék 2000; 10(80): 579-581.
- Peterová V, Seidl Z, Obenberger J. Přínos myorelaxancií k terapii tenzní cefaley. Prakt lék 1999; 79: 33-35.
- Stewart WF, Schechter A, Rasmussen BK. Migraine prevalence: a review of population - based studies. Neurology 1994; 44(Suppl 4): S17-23.
- Peterová V, Seidl Z, Viták T, Daneš J. Migrenózní aura. Čes Slov Neurol Neurochir 2003; 66/99(4): 297-303.
- Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 1995; 15: 140-144.
Go to original source... 
Go to PubMed... - Chen LC, Ashcroft DM. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache 2008; 48(2): 236-247. Go to original source... Go to PubMed...
- Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache 2007; 47(3): 355-363. Go to original source...
- Ng-Mak DS, Hu XH, Chen YT, Ma L. Acute migraine treatment with oral triptans and NSAIDs in a managed care population. Headache 2008; 48(8): 1176-1185. Go to original source... Go to PubMed...
- Cady RK, Maizels M, Reeves DL, Levinson DM, Evans JK. Predictors of adherence to triptans: factors of sustained vs lapsed users. Headache 2009; 49(3): 386-394. Go to original source... Go to PubMed...